PKM
A Piruvato Quinase M2 (PKM2) é uma isoforma da piruvato quinase que desempenha um papel crucial na glicólise, convertendo fosfoenolpiruvato em piruvato. PKM2 está envolvida na regulação da reprogramação metabólica em células cancerosas, tornando-se um alvo potencial para a terapia do câncer. Inibidores de PKM2 podem alterar as vias metabólicas, reduzir o crescimento tumoral e induzir a morte celular em células cancerígenas. Na CymitQuimica, oferecemos inibidores de PKM2 para apoiar sua pesquisa em metabolismo do câncer, oncologia e desenvolvimento terapêutico.
Foram encontrados 15 produtos de "PKM"
Ordenar por
Pureza (%)
0
100
|
0
|
50
|
90
|
95
|
100
PKR-IN-2
CAS:<p>PKR-IN-2 is a activator of pyruvate kinase (PKR).</p>Fórmula:C24H28N4O4SPureza:99.14%Cor e Forma:SolidPeso molecular:468.57PKCζ/ι pseudosubstrate inhibitor
CAS:<p>PKCζ/ι pseudosubstrate inhibitor demonstrates comprehensive inhibitory activity across the protein kinase C (PKC) family and is associated with the induction of</p>Fórmula:C76H128N30O16Cor e Forma:SolidPeso molecular:1718.02Dimethylaminomicheliolide HCl
CAS:<p>Dimethylaminomicheliolide HCl has potential anti-inflammatory and anti-tumor activity and inhibits the proliferation of glioblastoma cells by targeting pyruvate</p>Fórmula:C17H28ClNO3Pureza:99.55%Cor e Forma:SoildPeso molecular:329.86PKM2-IN-10
<p>PKM2-IN-10 is a PKM2 inhibitor. It effectively suppresses the proliferation of A549 and HCC1833 cell lines with IC50 values of 3.36 μM and 9.20 μM, respectively. PKM2-IN-10 demonstrates antitumor activity in human non-small cell lung cancer (NSCLC) and mouse lung adenocarcinoma models. It is applicable for research in lung cancer.</p>Fórmula:C21H15F4N5Cor e Forma:SolidPeso molecular:413.12636PKM2 inhibitor G
CAS:<p>PKM2 inhibitor G is a inhibitor of pyruvate kinase.</p>Fórmula:C16H15NO3SPureza:99.89%Cor e Forma:SoildPeso molecular:301.36Mitapivat sulfate hydrate
CAS:<p>Mitapivat sulfate hydrate (AG 348 sulfate hydrate) is a pyruvate kinase (PK) allosteric activator, used to study pyruvate kinase deficiency.</p>Fórmula:C24H26N4O3S1H2SO43H2OPureza:99.22%Cor e Forma:SolidPeso molecular:526.6DASA-58
CAS:<p>DASA-58 is a specific and potent Pyruvate kinase M2 (PKM2) activator.</p>Fórmula:C19H23N3O6S2Pureza:96.96% - 99.28%Cor e Forma:SolidPeso molecular:453.53Mitapivat
CAS:<p>Mitapivat (PKR-IN-1), also known as PKM2 activator 1020 is a PKM2 activator (pyruvate kinase activator) for the treatment of pyruvate kinase deficiency.</p>Fórmula:C24H26N4O3SPureza:99.47% - 99.83%Cor e Forma:SolidPeso molecular:450.55PKM2-IN-1
CAS:<p>PKM2-IN-1 (compound 3k) displays PKM2 inhibitory activity with the IC50 value of 2.95 μM. The IC50 value for PKM1 is 4-5-fold higher than that for PKM2.</p>Fórmula:C18H19NO2S2Pureza:99.49% - 99.68%Cor e Forma:SolidPeso molecular:345.48TEPP-46
CAS:<p>TEPP-46 (ML265) is an activator of pyruvate kinase M2 (PKM2), selective for PKM1, PKL and PKR. TEPP-46 has antitumor activity. Cost-effective and quality-assured.</p>Fórmula:C17H16N4O2S2Pureza:98.21% - 98.77%Cor e Forma:SolidPeso molecular:372.46PKM2 activator 5
CAS:<p>PKM2 activator 5 is a novel and potent PKM2 activator (AC50: 0.316 µM) with potential anticancer activity for the study of cancer metabolism-related diseases.</p>Fórmula:C18H19FN2O6S2Pureza:98%Cor e Forma:SolidPeso molecular:442.48PKM2 activator 2
CAS:<p>PKM2 activator 2 is a pyruvate kinase M2 (PKM2) activator with an AC 50 value of 66 nM.PKM2 activator 2 has anti-tumor proliferative properties and attenuates</p>Fórmula:C20H18F2N2O4S2Pureza:99.92%Cor e Forma:SolidPeso molecular:452.49PKM2-IN-9
CAS:<p>PKM2-IN-9 (compound C1) is a potent inhibitor of PKM2, demonstrating a 75% inhibition rate at 50 μM. It plays a significant role in cancer research.</p>Fórmula:C24H22N4O2Cor e Forma:SolidPeso molecular:398.457Mitapivat hydrochloride
CAS:<p>Mitapivat (AG-348) hydrochloride is an orally active and selective allosteric activator of pyruvate kinase R (PK-R). It enhances the PK-R-catalyzed conversion of phosphoenolpyruvate to pyruvate, thereby promoting the glycolysis pathway, increasing ATP production in red blood cells, and decreasing 2,3-diphosphoglycerate (2,3-DPG) levels. Mitapivat hydrochloride is being investigated for potential use in the study of pyruvate kinase deficiency and other anemia-related disorders.</p>Fórmula:C24H27ClN4O3SCor e Forma:SolidPeso molecular:487.014PKR Inhibitor, negative control
CAS:<p>The PKR Inhibitor, negative control, is an inactive structural analog of RNA-dependent protein kinase (PKR) inhibitors, serving as a negative control. Additionally, it can inhibit LK-induced neuronal death, demonstrating significant neuroprotective properties.</p>Fórmula:C15H8Cl3NO2Peso molecular:340.59
